St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors

Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain and solid tumors.

Related Keywords

United States ,American ,Heather Sheppard ,Haley Houke ,Unmesha Thanekar ,Jorge Ibanez ,Nikhil Hebbar ,Giedre Krenciute ,Zhongzhen Yi ,Stephen Mack ,Jason Chiang ,Chris Nevitt ,Paulina Velasquez ,Research Fellowship ,National Cancer Institute ,Jude Children Research Hospital ,Jude Department Of Bone Marrow Transplantation ,American Brain Tumor Association ,National Institutes Of Health ,Ibanez ,Jude Children ,Research Hospital ,Cell Reports ,Jude Department ,Bone Marrow Transplantation ,Meghan Ward ,Liqing Tian ,National Institutes ,Chadtough Defeat ,Basic Research Fellowship ,Cancer ,Ntigen ,One ,Bone Marrow ,Rain ,Ancer Immunotherapy ,Fell ,Children ,Chimeric Antigen Receptor ,Glucose ,Hospital ,Immunotherapy ,Leukemia ,Medicine ,Mh ,Protein ,Eceptor ,Research ,T Cell ,Humor ,